CXCL8 and breast carcinoma: In agreement, Ginestier et al. have shown that IL-8 could be used to target CSCs in breast cancer metastasis using either an antibody against the IL-8 receptor CXCR1 or repertaxin, a small molecule CXCR1 inhibitor [68].